Search results for " Right"

showing 10 items of 1166 documents

Right Heart Dysfunction and Readmission Risk Across Left Ventricular Ejection Fraction Status in Patients With Acute Heart Failure.

2021

BACKGROUND: Right heart dysfunction (RHD) parameters are increasingly important in heart failure (HF). This study aimed to evaluate the association of advanced RHD with the risk of recurrent admissions across the spectrum of left ventricular ejection fraction (LVEF). METHODS AND RESULTS: We included 3383 consecutive patients discharged for acute HF. Of them, in 1435 patients (42.4%), the pulmonary artery systolic pressure could not be measured accurately, leaving a final sample size of 1948 patients. Advanced RHD was defined as the combination of a ratio of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure of less than 0.36 and significant tricuspid regurgitation…

medicine.medical_specialtyVentricular Dysfunction RightHeart failureRegurgitation (circulation)Patient ReadmissionVentricular Function LeftreadmissionsVentricular Dysfunction LeftInterquartile rangemedicine.arteryInternal medicinemedicineHumansHeart FailureEjection fractionbusiness.industryStroke Volumeleft ventricular ejection fractionmedicine.diseasePrognosisBlood pressureSample size determinationHeart failurePulmonary arteryRight heartCardiologyVentricular Function RightCardiology and Cardiovascular Medicinebusinessright heart dysfunction
researchProduct

Defining right ventricular dysfunction by the use of echocardiography in normotensive patients with pulmonary embolism

2020

Although the prognostic value of various echocardiographic parameters of right ventricular dysfunction (RVD) was reported in normotensive patients with acute pulmonary embolism (PE), there is no generally accepted definition of RVD.The aim of the study was to compare echocardiographic parameters for the prediction of an adverse 30‑day outcome and create an optimal definition of RVD.                                     Patients and methods: Echocardiographic parameters including the right ventricular to left ventricular diameter ratio (RV to LV ratio) and tricuspid annular plane systolic excursion (TAPSE) to predict PE‑related mortality, hemodynamic collapse, or rescue thrombolysis within th…

medicine.medical_specialtyVentricular Dysfunction Rightmedicine.medical_treatmentHemodynamicsBlood Pressure030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineHumansMedicineProspective Studies030212 general & internal medicineReceiver operating characteristicbusiness.industryArea under the curveThrombolysismedicine.diseaseRight ventricular dysfunction3. Good healthPulmonary embolismBlood pressureIncreased riskEchocardiographyCardiologyPulmonary EmbolismbusinessPolish Archives of Internal Medicine
researchProduct

Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis

2021

BACKGROUND Tricuspid regurgitation (TR) has a poor prognosis and limited treatment options and is frequently accompanied by right ventricular (RV) dysfunction. Transcatheter tricuspid valve interventions (TTVI) to reduce TR have been shown to be safe and feasible with encouraging early results. Patient selection for TTVI remains challenging, with the role of right ventricular (RV) function being unknown. AIMS The aims of this study were 1) to investigate survival in a TTVI-treated patient population and a conservatively treated TR population, and 2) to evaluate the outcome of TTVI as compared to conservative treatment stratified according to the degree of RV function. METHODS We studied 684…

medicine.medical_specialtyeducation.field_of_studyTricuspid valveVentricular functionbusiness.industryVentricular Dysfunction RightMortality rateHazard ratioPopulationTertiary careTricuspid Valve InsufficiencyTreatment Outcomemedicine.anatomical_structureInternal medicinePropensity score matchingCohortVentricular Function RightmedicineCardiologyHumansTricuspid ValveCardiology and Cardiovascular MedicineeducationbusinessEuroIntervention
researchProduct

Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art

2014

No abstract available

medicine.medical_specialtymedicine.medical_treatmentDecision MakingCardiomyopathySudden deathImplantable cardioverter-defibrillatorAntiarrhythmic drugs; Cardiac transplantation; Implantable cardioverter-defibrillator; Management; Radiofrequency catheter ablation; Sudden death; Arrhythmogenic Right Ventricular Dysplasia; Decision Making; HumansAntiarrhythmic drugs; Cardiac transplantation; Implantable cardioverter-defibrillator; Management; Radiofrequency catheter ablation; Sudden deathInternal medicinemedicineHumansIn patientIntensive care medicineArrhythmogenic Right Ventricular DysplasiaRadiofrequency catheter ablationbusiness.industrySudden deathImplantable cardioverter-defibrillatormedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareArrhythmogenic right ventricular dysplasiaAntiarrhythmic drugsManagementAntiarrhythmic drugRadiofrequency catheter ablationCardiologyCardiac transplantationTreatment decision makingCardiology and Cardiovascular Medicinebusiness
researchProduct

Thrombolytic therapy for submassive pulmonary embolism.

2012

Approximately 10% of all patients with acute pulmonary embolism (PE) die within the first three months after diagnosis. However, PE is not universally life-threatening, but covers a wide spectrum of clinical severity and death risk. Thrombolytic treatment is indicated patients with acute massive PE who are at high risk for early death, i.e. those patients who present with arterial hypotension and shock. On the other hand, low molecular-weight heparin or fondaparinux is adequate treatment for most normotensive patients with PE. Recombinant tissue plasminogen activator, given as 100 mg infusion over 2 h, is the treatment of choice for patients with PE, although older regimens using urokinase …

medicine.medical_specialtymedicine.medical_treatmentStreptokinaseVentricular Dysfunction RightClinical Biochemistry030204 cardiovascular system & hematologyFondaparinuxlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialFibrinolytic AgentslawPolysaccharidesRisk FactorsInternal medicinemedicineHumansStreptokinaseThrombolytic Therapy030212 general & internal medicineIntensive care medicineUrokinaseClinical Trials as Topicbusiness.industryHeparinThrombolysisHeparin Low-Molecular-Weightmedicine.diseaseUrokinase-Type Plasminogen ActivatorTroponin3. Good healthPulmonary embolismRadiographyOncologyFondaparinuxTissue Plasminogen ActivatorAcute DiseaseCardiologybusinessPulmonary EmbolismBiomarkersmedicine.drugCohort studyBest practiceresearch. Clinical haematology
researchProduct

Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism Internation…

2021

Intermediate-high-risk pulmonary embolism (PE) is characterized by right ventricular (RV) dysfunction and elevated circulating cardiac troponin levels despite apparent hemodynamic stability at presentation. In these patients, full-dose systemic thrombolysis reduced the risk of hemodynamic decompensation or death but increased the risk of life-threatening bleeding. Reduced-dose thrombolysis may be capable of improving safety while maintaining reperfusion efficacy. The Pulmonary Embolism International THrOmbolysis (PEITHO)-3 study (ClinicalTrials.gov Identifier: NCT04430569) is a randomized, placebo-controlled, double-blind, multicenter, multinational trial with long-term follow-up. We will c…

medicine.medical_specialtypulmonary embolismVentricular Dysfunction Rightmedicine.medical_treatment2720 HematologyHemodynamicsHemorrhage610 Medicine & health030204 cardiovascular system & hematologyintermediate-high-risk; prognosis; pulmonary embolism; randomized trial; reduced-dose thrombolysis03 medical and health sciences0302 clinical medicineFibrinolytic AgentsInternal medicinemedicinerandomized trialHumansThrombolytic TherapyDecompensationStrokeHeparinbusiness.industry10031 Clinic for AngiologyHematologyThrombolysismedicine.diseasereduced-dose thrombolysis3. Good healthPulmonary embolismRegimenTreatment OutcomeBlood pressure030228 respiratory systemTissue Plasminogen ActivatorHeart failureAcute DiseaseCardiologyprognosisintermediate-high-riskbusiness
researchProduct

Rumor de pañuelo blanco: historia, memoria y representaciones literarias de Abuelas de Plaza de Mayo

2018

El 24 de marzo de 2016 se cumplieron 40 años del golpe de Estado del autodenominado Proceso de Reorganización Nacional que condujo a siete años de una sangrienta dictadura en Argentina. De entre las organizaciones de Derechos Humanos que surgieron como respuesta a las desapariciones ilegales de militantes y de civiles, las Madres y Abuelas de Plaza de Mayo se han constituido, tanto a nivel nacional como internacional, en evidencia de la historia de violencia y en símbolo de paz; como tales también han entrado en el plano de la ficción. Teniendo en cuenta estas líneas, en el presente trabajo se realiza, primero, un recorrido por la historia de las Abuelas de Plaza de Mayo y el cambio polític…

memoriaHistoryLiterature and Literary TheoryHuman rightsmedia_common.quotation_subjectDictadura argentinaDictatorship ArgentinaliteraturaDictatorshipGrandmothers of Plaza de MayoSymbolLiteratureMemoryRealmAbuelas de Plaza de MayoHumanitiesmedia_common
researchProduct

Covid-19 and Inequalities. Protecting Human Rights of Migrants in a Time of Pandemic

2020

By focusing on the Italian context, this article explores the human rights violations that migrants systematically experience and that the current health crisis is unveiling and, in turn, producing. In particular, we look at these dynamics by taking into account four issues/dimensions: the access to essential services and benefits, such as food vouchers; working and living conditions; conditions in reception and detention centres; and the denial of entry to reach ports of safety.

migrant rightinequalitiehuman rightSettore SPS/12 - Sociologia Giuridica della Devianza e Mutamento SocialeSettore IUS/02 - Diritto Privato ComparatoCovid-19exploitation
researchProduct

MIGRATIONS AND THE CENTER OF THE AFRICAN FACE OF SICILY

2010

inglese

migration african face of sicily multi-ethnic city human rightsSettore ICAR/21 - Urbanistica
researchProduct

Menores extranjeros no acompañados en Italia: una reflexión acerca de las políticas de acogida y los servicios para la tutela de los derechos.

2015

The presence of foreign children in Italy has become increasingly significant, favoured by some circumstances of great legal and social relevance: the enactment of favourable legislative conditions for family union, an increase in births of immigrant children in Italy due to the achieved families settlement, the increased presence of unaccompanied foreign minors. The Italian legal system has recognized the foreign minor, which for various reasons is present in its territory, the same fundamental rights of citizen minors. They are fundamental rights that correspond to meritorious needs for its essentiality in the development of personality, be legislatively secured; beyond the right to citiz…

minori stranieri non accompagnatitutela dei dirittiUnaccompanied Migrant MinorMigraciónmenores extranjeros no acompañadoSettore SPS/07 - Sociologia GeneralemigrazioniProtection of rightMigrationtutela de los derecho
researchProduct